Literature DB >> 3771868

Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone.

J S Fortson, J J Zone, M E Hammond, G C Groggel.   

Abstract

A 45-year-old woman with cutaneous urticaria-like lesions subsequently developed polyarthritis, glomerulonephritis, and chronic obstructive pulmonary disease. Biopsy of skin showed leukocytoclastic vasculitis of superficial capillaries. Biopsy of the kidney revealed mesangioproliferative glomerulonephritis, and lung biopsy revealed severe emphysema and thick-walled blood vessels with immunoglobulin deposition. Therapy with dapsone produced dramatic improvement of the patient's cutaneous vasculitis and arthritis. This case uniquely demonstrates the efficacy of dapsone for both the urticarial vasculitic and the arthritic components of this syndrome and reemphasizes the potentially severe pulmonary and renal complications.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771868     DOI: 10.1016/s0190-9622(86)70282-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  17 in total

1.  Dapsone in Henoch-Schönlein purpura--worth a trial.

Authors:  B I Hoffbrand
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

Review 2.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

3.  Juvenile systemic lupus erythematosus and dermatomyositis associated with urticarial vasculitis syndrome: a unique presentation.

Authors:  Patrícia A Macêdo; Carolina B Garcia; Monique K Schmitz; Levi H Jales; Rosa M R Pereira; Jozélio F Carvalho
Journal:  Rheumatol Int       Date:  2010-04-17       Impact factor: 2.631

Review 4.  Urticarial vasculitis.

Authors:  Joe Venzor; Wai L Lee; David P Huston
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

5.  Drug usage evaluation of dapsone.

Authors:  G Kannan; J Vasantha; N Vanitha Rani; P Thennarasu; K Kousalya; P Anuradha; C Umamaheswara Reddy
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

6.  Hypocomplementemic urticarial vasculitis in systemic lupus erythematosus.

Authors:  Min Young Her; Joo Yeon Song; Dong Yook Kim
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

7.  [Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins].

Authors:  P Staubach-Renz; E von Stebut; W Bräuninger; M Maurer; K Steinbrink
Journal:  Hautarzt       Date:  2007-08       Impact factor: 0.751

8.  Primary Cutaneous Small Vessel Vasculitis.

Authors:  James P. Russell; Roger H. Weenig
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04

9.  Hypocomplementemic urticarial vasculitis syndrome with gastrointestinal vasculitis and crescentic membranoproliferative glomerulonephritis without immune complex deposits.

Authors:  Kenji Ueki; Akihiro Tsuchimoto; Yuta Matsukuma; Kumiko Torisu; Kiichiro Fujisaki; Takehiro Torisu; Yuichi Yamada; Yoshinao Oda; Kosuke Masutani; Toshiaki Nakano; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  CEN Case Rep       Date:  2019-10-04

Review 10.  Urticaria. Recognition, causes and treatment.

Authors:  A D Ormerod
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.